References
- Viegi G, Annesi I, Mattelli G. Epidemiology of asthma. Asthma, F Chung, L M Fabbri. ERS Journals Ltd., UK 2003; 2–25, European Respiratory Monograph 2003(23)
- Global strategy for asthma management and prevention. National Heart, Lung and Blood Institute. National Institute of Health, Bethesda, MarylandUSA 2002, www.ginasthma.com
- World Health Organization (WHO). Bronchial asthma, WHO Fact Sheet No 206. Revised January 2000
- Thomsen S F, Ulrik C S, Kyvik K O, et al. Risk factors for asthma in young adults: a co-twin control study. Allergy 2006; 61(2)229–233
- Polosa R, Al-Delaimy W K, Russo C, et al. Greater risk of incident asthma cases in adults with allergic rhinitis and effect of allergen immunotherapy: a retrospective cohort study. Respir Res 2005; 28(6)153
- Carolien I, Panhuysen I C, Vonk M J, et al. Adult patients may outgrow their asthma (A 25-year follow-up study). Am J Respir Crit Care Med 1997; 155: 1267–1272
- Suppli C, Backer V, Dirksen A. A 10 year follow up of 180 adults with bronchial asthma: factors important for the decline in lung function. Thorax 1992; 47: 14–18
- Szefler S J. The natural history of asthma and early intervention. J Allergy Clin Immunol 2002; 109(Suppl 6)549–553
- Kitch B T, Paltiel A D, Kuntz K M, et al. A single measure of FEV1 is associated with risk of asthma attacks in long term follow-up. Chest 2004; 126(6)1875–1882
- Strachan D P, Butland B K, Anderson H R. Incidence and prognosis of asthma and wheezing illness from early childhood to age 33 in a national British cohort. Br Med J 1996; 312: 1195–1199
- Halasz A, Cserhati E. The prognosis of Bronchial Asthma in childhood in Hungary: A long-term follow-up. J Asthma 2002; 39(8)693–699
- Roorda R J, Gerritsen J, Van Aalderen W M, et al. Follow-up of asthma from childhood to adulthood: Influence of potential childhood risk factors on the outcome of pulmonary function and bronchial responsiveness in adulthood. J Allergy Clin Immunol 1994; 93: 575–584
- Blair H. Natural history of childhood asthma (20-years follow-up). Arch Dis Child 1977; 52: 613–619
- American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. Am Rev Respir Dis 1987; 136: 225–244
- American Thoracic Society. Standardization of spirometry (1994 update). Am J Respir Crit Care Med 1995; 152: 1107–1136
- Cockcroft D W. Bronchial inhalation tests I. Measurement of nonallergic bronchial responsiveness. Ann Allergy 1985; 4: 527–534
- Chin S. Comparing and combining studies of bronchial responsiveness. Thorax 2002; 57: 393–395
- Chin S. Methodology of bronchial responsiveness. Thorax 2002; 53(11)984
- Cockroft D W, Berscheid B A, Murdock K Y. Measurement of responsiveness to inhaled histamine using FEV1: comparison of PC20 and threshold. Thorax 1983; 38: 523–526
- O'Connor G, Sparrow D, Taylor D, et al. Analysis of dose-response curves to methacholine. Am Rev Respir Dis 1987; 136: 1412–1417
- American Thoracic Society. Guidelines for methacholine and exercise challenge testing-1999. Am J Respir Crit Care Med 2000; 161: 309–327
- Niemeijer N R, De Monchy J G. Age-dependency of sensitization to aeroallergens in asthmatics. Allergy 1992; 47: 431–435
- Gioulekas D, Chatzigeorgiou G, Spieksma F. Allergenic pollen and pollinosis in northern Greece. Allergenic pollen and pollinosis in Europe, G D'Amato, F T Spieksma, S Bonini. Blackwell Scientific Publications, Melbourne, Paris, Berlin, Vienna 1991; 167–171
- Girodet P O, Casset A, Magnan A, et al. IgE and respiratory disease. Rev Mal Respir 2005; 26(6)423–427
- Rothenberg M F. The eosinofils. Annu Rev Immunol 2006; 24: 147–174
- Bel E. Clinical phenotypes of asthma. Curr Opin Pulm Med 2003; 10: 44–50
- Papageorgiou N, Gaga M, Marossis C, et al. Prevalence of asthma and asthma-like symptoms in Athens, Greece. Respir Med 1997; 91(2)83–88
- The ENFUMOZA Study Group. The ENFUMOZA cross-sectional European multicentre study of the clinical phenotype of chronic severe asthma. Eur Respir J 2003; 22: 470–477
- Borish L, Chipps B, Deniz Y, et al. For the TENOR Study Group. Total serum IgE levels in a large cohort of patients with severe or difficult-to-treat asthma. Ann Allergy Asthma Immunol 2005; 95: 247–253
- Carolien I, Panhuysen I C, Vonk M J, et al. Adult patients may outgrow their asthma (A 25-year follow-up study). Am J Respir Crit Care Med 1997; 155: 1267–1272
- Mc Niicol K N, Williams H F. Spectrum of asthma in children. BMJ 1973; 4: 7–11
- Ogilvie A. Asthma. A study in prognosis of 1000 patients. Thorax 1962; 17: 183–189
- Skobeloff E M, Spivey W H, St Clair S S, Schoffstall J M. The influence of age and sex on asthma admissions. JAMA 1992; 268: 3437–3440
- Lombardi C, Passalacqua G, Gargioni S, et al. The natural history of respiratory allergy: A follow-up study of 99 patients up to 10 years. Respir Med 2001; 95: 9–12
- Grol M H, Gerritsen J, Vonk J M, et al. Risk factors for growth and decline of lung function in asthmatic individuals up to age 42 years (a 30-years follow-up study). Am J Respir Crit Care Med 1999; 160: 1830–1837
- Holberg S, Enright P, Lebowits M, et al. Longitudinal analysis of the effects of smoking onset and cessation on pulmonary function. Am J Respir Crit Care Med 1994; 149: 591–597
- Corren J. The impact of allergic rhinitis on bronchial asthma. J Allergy Clin Immunol 1998; 101: 352–356
- Schayck C P, Dompeling C L, Herwaarden A M, et al. Interacting effects of atopy and bronchial hyperresponsiveness on the annual decline in lung function and the exacerbation rate in asthma. Am Rev Respir Dis 1991; 144: 1297–1301
- Peat J K, Woolcock A J, Cullen K. Rate of decline of lung function in subjects with asthma. Eur J Respir Dis 1987; 70: 171–179
- Kelly W JW, Hudson I, Raven J, et al. Childhood asthma and adult lung function. Am Rev Respir Dis 1988; 138: 26–30
- O'Byrne P M, Bisgaard H, Godard P P, et al. Budesonide/Formoterol combination therapy as both maintenance and reliever medication in asthma. Am J Respir Crit Care Med 2005; 171: 129–136
- Rabe K F, Atienza T, Magyar P, et al. Effect of budesonide in combination with formoterol for reliever therapy in asthma exacerbations: a randomised controlled, double-blind study. Lancet 2006; 368: 744–753
- Bousquet J, Boulet L P, Peters M J, et al. Budesonide/formoterol for maintance and relief in uncontrolled asthma vs. high-dose salmeterol/fluticasone. Respir Med 2007; 101: 2347–2446
- Papi A, Canonica G W, Maestrelli P, et al. Rescue use of beclomethazone and albuterol in a single inhaler for mild asthma. N Engl J Med 2007; 356: 2040–2052